To demonstrate the cooperation and translational significance of ATO and ATRA in targeting Pin1 for treating cancers, we chose TNBC as a model system because unlike APL, which is basically cured by ATO and ATRA10–12, TNBC has the worst prognosis of all breast cancer subtypes and no targeted therapy is available59. This evidence concerns the gene PIN1 and breast carcinoma.